Compositions and methods for inhibiting expression of CD274/PD-L1 gene
US-9422562-B2 · Aug 23, 2016 · US
This page is not indexed by search engines while we improve data quality.
Alnylam Pharmaceuticals patents
Alnylam Pharmaceuticals holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 0 |
| First publication | Mar 26, 2015 |
| Latest publication | Aug 23, 2016 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Serpinc1 iRNA compositions and methods of use thereof
US-9127274-B2 · Sep 8, 2015 · US
Microrna compositions and methods
US-2015087607-A1 · Mar 26, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
US-9422562-B2 · Aug 23, 2016 · US
Serpinc1 iRNA compositions and methods of use thereof
US-9127274-B2 · Sep 8, 2015 · US
Microrna compositions and methods
US-2015087607-A1 · Mar 26, 2015 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K31/713 | 3 |
| C12N15/113 | 2 |
| A61P43/00 | 2 |
| C12N2310/321 | 2 |
| C12N2310/14 | 2 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 3 |
| Cross-Sectional Technologies | 1 |